Study of the Anti-tumoral Immune Response

Inclusion Criteria: * Performance status 0,1 or 2 * breast cancer or glioma * Arm glioma: patients without anti-tumoral treatment * Arm breast cancer: inclusion before treatment * Arm breast cancer HER2: patients with current therapy Exclusion Criteria: * Psychiatric disease compromising the understanding of the information or the realization of the study * vulnerable People according to the law (minors, adults under protection, private persons of freedom ...) * Unaffiliated People to the Social Security * People being for the period of exclusion from another study * Life expectancy estimated unless 3 months. * For patients in Arm glioma: patients having already begun a systematic treatment. * For patients with a breast cancer: patient already under current therapy